QurieGen (former Monoceros Analytics) is a spin-off of the Radboud University that will support pharmaceutical companies in the early identification of successful drug molecules by offering high-resolution unbiased molecular insights into their mode of action. By doing this, the aim is to enable rapid decision-making during drug design cycles in order to better determine what drugs could be successful.
Drug Development & Discovery
Complies with the following Sustainable Development Goals:
SDG3: Good health and well-being thanks to our solution.